CUL5 and cervical carcinoma: CUL5 depletion impedes mitotic exit and enhances the chemosensitivity of cervical carcinoma HeLa cells to paclitaxel by downregulating APC11, in both in vitro cell cultures and in vivo xenograft tumor models.